Inflammasome Therapeutics develops therapies for prevalent, degenerative diseases like Alzheimer’s disease and Parkinson's disease.
Inflammasome Therapeutics has raised $13.2M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2026.
Inflammasome Therapeutics is headquartered in Newton, United States.
Inflammasome Therapeutics develops therapies for prevalent, degenerative diseases like Alzheimer’s disease and Parkinson's disease.
Inflammasome Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Inflammasome Therapeutics — Funding & Investors." VCBacked, May 4, 2026, https://www.vcbacked.co/company/inflammasome-therapeutics. Accessed August 13, 2026.
VCBacked. (2026). Inflammasome Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/inflammasome-therapeutics
{{cite web |title=Inflammasome Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/inflammasome-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated